Oxecta

Oxecta is a brand name of oxycodone, approved by the FDA in the following formulation(s):

OXECTA (oxycodone hydrochloride - tablet; oral)

• 
  Manufacturer: KING PHARMS R AND D
  
  Approval date: June 17, 2011
  
  Strength(s): 5MG, 7.5MG
  

Has a generic version of Oxecta been approved?

No. There is currently no therapeutically equivalent version of Oxecta available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Oxecta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Methods and compositions for deterring abuse of opioid containing dosage forms
  Patent 7,201,920
  Issued: April 10, 2007
  Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
  Assignee(s): Acura Pharmaceuticals, Inc.
  This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
  
  Patent expiration dates:
  
  
  • March 16, 2025
    
    ✓ 
    Drug product
  
  



• 
  Methods and compositions for deterring abuse of opioid containing dosage forms
  Patent 7,510,726
  Issued: March 31, 2009
  Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
  Assignee(s): Acura Pharmaceuticals, Inc.
  This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
  
  Patent expiration dates:
  
  
  • November 26, 2023
    
    ✓ 
    Drug product
  
  



• 
  Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
  Patent 7,981,439
  Issued: July 19, 2011
  Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
  Assignee(s): Acura Pharmaceuticals, Inc.
  This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
  
  Patent expiration dates:
  
  
  • November 26, 2023
    
    ✓ 
    Drug product
  
  

See also...

• Oxecta Consumer Information (Drugs.com)
• Oxecta Advanced Consumer Information (Micromedex)
• Oxycodone Consumer Information (Drugs.com)
• Oxycodone Consumer Information (Wolters Kluwer)
• Oxycodone Concentrate Consumer Information (Wolters Kluwer)
• Oxycodone Solution Consumer Information (Wolters Kluwer)
• Oxycodone Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Oxycodone Consumer Information (Cerner Multum)
• Oxy IR Advanced Consumer Information (Micromedex)
• Oxycontin CR Advanced Consumer Information (Micromedex)
• Oxycodone Advanced Consumer Information (Micromedex)
• Oxycodone AHFS DI Monographs (ASHP)
• Oxycodone Hydrochloride AHFS DI Monographs (ASHP)